Correction to: Journal of Human Hypertension (2009) 23, 188–195; doi:10.1038/jhh.2008.116; published online 18 September 2008
The authors would like to correct the affiliation of Nobuo Shirahashi, who was included in appendix as part of the statistical analysis organization.
Therefore, the sentence:
‘K Yagi, Louis Pasteur Center for Medical Research, Kyoto, Japan; Nobuo Shirahashi, Department of Preventive Medicine and Environmental Health, Osaka City University Medical School, Osaka, Japan.’
Should read:
‘K Yagi, Louis Pasteur Center for Medical Research, Kyoto, Japan; Nobuo Shirahashi, Novartis Pharma KK.’
Author information
Consortia
Additional information
The online version of the original article can be found at 10.1038/jhh.2008.116
Rights and permissions
About this article
Cite this article
Sawada, T., Takahashi, T., Yamada, H. et al. Erratum: Rationale and design of the KYOTO HEART study: effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events. J Hum Hypertens 27, 580 (2013). https://doi.org/10.1038/jhh.2013.57
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2013.57